Navigation Links
Treatment Resistant Tumors Can Be Targeted Better Using Botox

Botox, commonly used for cosmetic treatment may play an important role in enhancing the outcome of chemotherapy and radiotherapy, employed in cancer treatment. // Botox is a derivative of Botulinum toxin, a naturally occurring chemical known to cause intestinal poisoning.

The toxin has numerous clinical applications such as relieving facial spasms, strabismus and treating muscle hyperactivity. The toxin acts by blocking release of acetylcholine and norepinephrine (neurotransmitters).

It is hypothesized that this neurotransmitter release inhibition could inhibit neuromuscular contraction of blood vessels that supply the tumor. This could eventually pave way for enhanced tumor perfusion, allowing effective delivery of cytotoxic drugs and oxygen (improves tumor response to radiotherapy) supplied to the tumor.

To verify the above hypothesis, Dr. Bernard Gallez and his research team injected Botulinum neurotoxin (Type A) into mouse tumors. As expected, the vascular architecture of the tumor opened, destroying the previously resistant cancer cells. The study is the first of its kind to test the use of Botox as an adjuvant in the effective treatment of resistant tumors.

In addition, pre-treatment with Botox delayed further growth of the tumor and promoted apoptosis, that could enhance the clinical outcome of cancer treatment. Based on further research in the same direction, it might even be possible to overcome drug resistance or reduce standard radiotherapy and chemotherapy dosages, thereby eliminating the associated side effects.

Until now, much of cancer treatment has been focused towards starving the tumor of its blood supply. This new approach, targeted at enhanced blood supply for effective delivery of chemotherapeutic agents and radiation represents a new dimension of cancer research.

'Tumor vasculature is targeted by several advanced anti-cancer approaches that may appear contradic tory. Anti-angiogenesis and anti-vascular targeting are methods aimed at destroying the vessels that feed tumors, thereby depriving them of oxygen and nutrients. In contrast, pro-vascular approaches increase tumor perfusion and oxygenation temporarily,' concluded Dr. Gallez.


'"/>




Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2019)... ... May 22, 2019 , ... Care to ... Health studying the economic impact of misdiagnosis of imaging procedures. According to Lisa ... the interpretations of the diagnostic imaging their employees were receiving, including CT scans ...
(Date:5/22/2019)... ... 22, 2019 , ... The Josh Bersin Academy, the world’s ... at Work, an Academy program developed in partnership with Virgin Pulse and focusing ... examples for creating a holistic corporate wellbeing program and suggestions for making a ...
(Date:5/22/2019)... , ... May 22, 2019 , ... The Power of ... The fashion expert and creator shares seven ways for women to step into their ... Power of Color combines spirituality, music, and dancing to further self-expression. Women looking to ...
(Date:5/21/2019)... CHURCH, Va. (PRWEB) , ... May 22, 2019 ... ... Interactive Workshop Presented by FDAnews and ValSource, June 26-27, 2019 • Raleigh, NC, ... Your CMO:, An Interactive Workshop Presented by FDAnews and ValSource ends on May ...
(Date:5/21/2019)... ... 21, 2019 , ... Coral Detection Systems recently went to market with the ... 3000 uses advanced AI software and an underwater video camera to analyze, detect, and ... and alert upon any entrance to the water, and more importantly, upon detection of ...
Breaking Medicine News(10 mins):
(Date:5/22/2019)... ... 2019 , ... Adventist Health , a health system serving more than ... its partnership with CancerIQ as part of a system-wide effort to reduce ... platform will be integrated into the health system’s Cerner Electronic Health Record (EHR) to ...
(Date:5/22/2019)... ... May 22, 2019 , ... The Center for Information and Study on ... Appreciation 5K Run & Walk in conjunction with the Drug Information Association (DIA) at ... annual 5K salutes the millions of “Medical Heroes” who have given the gift of ...
(Date:5/22/2019)... ... 2019 , ... ActiGraph , the leading provider of ... data analytics specialist VivoSense . The partnership will enhance the ability of ... data from patients participating in pharmaceutical clinical trials. VivoSense is a regulatory compliant, ...
Breaking Medicine Technology: